TerSera Therapeutics LLC today announced that it has completed the previously announced sale of its Infusion Specialty Therapies Business Unit (IST), including two specialty medications, Prialt(R) ...

Jay Olson Oppenheimer & Co. Inc., Research Division. Hello, everyone, and welcome to Oppenheimer's 36th Annual Life Science Conference. I'm Jay Olson, one of the biotech analysts ...

Cross Keys Capital, LLC, a leading independent investment banking firm providing M&A advisory services to physician group ...

Camp4 Therapeutics FY25 GAAP EPS missed expectations, but ended the year with a robust cash position. Check out why CAMP ...

Salanersen, a treatment candidate for spinal muscular atrophy (SMA) now in clinical testing, is safe and was shown to stabilize or improve motor function over at least one year of follow-up in ...

The company's clinical development plan comprises three global Phase III studies, including two focused on infants and a third for older patients.

Spinraza treatment led to sustained improvements in motor function in adults with SMA, according to a South Korean study.

Behind a pretty shell sits a precision hunter whose toxins can stop a heartbeat, yet also power pain relief and new diabetes care.

New hypertension treatments may reduce dosage to two injections annually instead of daily pills Zilebesiran uses siRNA to lower blood pressure by targeting angiotensinogen production in the liver Long ...

Tablets could make treatment more mainstream, with sector predicted to be worth $200bn by end of the decade “I just felt slow: I want to be able to do anything my kids want to do and not have weight ...

MILAN — A plastic surgeon renowned for penis-enlarging procedures, including the injection of hyaluronic acid, says he provided the service last month to a ski jumper. The assertion comes with the ski ...